We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pharmathene, (delisted) | AMEX:PIP | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.00 | 01:00:00 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * Truffle Capital S.A.S. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol Altimmune, Inc. [ALT] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below) _____ Other (specify below) |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock, par value $0.0001 | 416043 (1) | I | See footnote (2) (3) |
Common Stock, par value $0.0001 | 230103 (1) | I | See footnote (2) (4) |
Common Stock, par value $0.0001 | 183690 (1) | I | See footnote (2) (5) |
Common Stock, par value $0.0001 | 179359 (1) | I | See footnote (2) (6) |
Common Stock, par value $0.0001 | 151441 (1) | I | See footnote (2) (7) |
Common Stock, par value $0.0001 | 116654 (1) | I | See footnote (2) (8) |
Common Stock, par value $0.0001 | 105804 (1) | I | See footnote (2) (9) |
Common Stock, par value $0.0001 | 113115 (1) | I | See footnote (2) (10) |
Common Stock, par value $0.0001 | 50767 (1) | I | See footnote (2) (11) |
Common Stock, par value $0.0001 | 1774 (1) | I | See footnote (2) (12) |
Common Stock, par value $0.0001 | 1255 (1) | I | See footnote (2) (13) |
Common Stock, par value $0.0001 | 10388 (1) | I | See footnote (2) (14) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (right to buy) | 5/4/2017 | 10/8/2018 | Common Stock | 364 (15) | $2.12 | I | See footnote (2) (16) |
Stock Option (right to buy) | 5/4/2017 | 10/8/2018 | Common Stock | 154 (15) | $2.12 | I | See footnote (2) (17) |
Stock Option (right to buy) | 5/4/2017 | 10/8/2018 | Common Stock | 18 (15) | $2.12 | I | See footnote (2) (18) |
Stock Option (right to buy) | 5/4/2017 | 10/8/2018 | Common Stock | 17 (15) | $2.12 | I | See footnote (2) (19) |
Remarks:
Exhibit 24.1 - Power of Attorney |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Truffle Capital S.A.S.
5, RUE DE LA BAUME PARIS, I0 75008 |
|
X |
|
|
Signatures
|
||
/s/ Ori Solomon, Attorney in fact for Philip Hodges | 5/15/2017 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Pharmathene, (delisted) Chart |
1 Month Pharmathene, (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions